Uchio Ryusei, Okuda-Hanafusa Chinatsu, Sakaguchi Haruka, Saji Ryosuke, Muroyama Koutarou, Murosaki Shinji, Yamamoto Yoshihiro, Hirose Yoshitaka
Research & Development Institute, House Wellness Foods Corp., Itami, Hyogo, Japan.
Front Nutr. 2024 Jan 29;11:1324196. doi: 10.3389/fnut.2024.1324196. eCollection 2024.
The spice turmeric, which has the Latin name (), has various physiological effects. This study evaluated the effects of a hot water mixture with supercritical carbon dioxide extracts, CLE, and the potential active components of , turmeronols A and B and bisacurone on inflammation and glucose metabolism. First, we investigated the effect of CLE and the potential active components of on lipopolysaccharide-induced inflammation in RAW264.7 macrophages. We found a significant decrease in the production of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and nitric oxide with CLE, turmeronol A, and bisacurone, Significant inhibition of each of these substances was also observed, except for TNF-α with turmeronol B. The second part of our work was a 12-week randomized, double-blind, placebo-controlled study in healthy but borderline adults aged 40 to 69 years with overweight and normal/prediabetes glycemia. We compared blood inflammatory and glycometabolic markers in the CLE ( = 55) and placebo groups ( = 55). We found significantly lower serum high-sensitivity C-reactive protein and hemoglobin A1c levels in the CLE group. This group also showed significant improvements in postprandial hyperglycemia and insulin sensitivity indices. Our findings indicate that CLE may reduce low-grade inflammation and thus improve insulin sensitivity and postprandial hyperglycemia. https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000051492, UMIN-CTR, UMIN000045106.
姜黄这种香料,其拉丁学名为(此处原文缺失拉丁学名),具有多种生理效应。本研究评估了超临界二氧化碳萃取物CLE与姜黄热水混合物以及姜黄的潜在活性成分——姜黄酮A和B以及双去甲氧基姜黄素对炎症和葡萄糖代谢的影响。首先,我们研究了CLE以及姜黄的潜在活性成分对脂多糖诱导的RAW264.7巨噬细胞炎症的影响。我们发现,CLE、姜黄酮A和双去甲氧基姜黄素能显著降低白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α和一氧化氮的产生,除了姜黄酮B对TNF-α外,其他物质也均有显著抑制作用。我们工作的第二部分是一项为期12周的随机、双盲、安慰剂对照研究,研究对象为40至69岁健康但血糖处于临界值、超重且血糖正常/处于糖尿病前期的成年人。我们比较了CLE组(n = 55)和安慰剂组(n = 55)的血液炎症和糖代谢标志物。我们发现CLE组的血清高敏C反应蛋白和糖化血红蛋白水平显著降低。该组在餐后高血糖和胰岛素敏感性指数方面也有显著改善。我们的研究结果表明,CLE可能会减轻低度炎症,从而改善胰岛素敏感性和餐后高血糖。https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000051492,UMIN-CTR,UMIN000045106 。